Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Alcobra (ADHD)

Add to Watchlists
Create an Alert
17.61 -0.23  -1.29% NASDAQ Apr 23, 5:00PM BATS Real time Currency in USD
View Full Chart
ADHD Price Chart
View All Performance Charts

ADHD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alcobra is up N/A over the last year vs S&P 500 Total Return up 22.59%, Shire up 80.34%, and Questcor Pharmaceuticals up 186.0%.

Get Quote for

Portfolio Strategies Featuring ADHD

Did Alcobra make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ADHD Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Israel
  • Headquarters State/Province: N/A
  • Incorporation Country: Israel
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Alcobra Ltd is a biopharmaceutical company which engaged in the development and commercialization of its proprietary drug, MG01CI, to treat attention deficit hyperactivity disorder.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ADHD 17.61 -0.23 -1.29% 240.14M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.